Clay Thorp is Director of Vigil Neuroscience, Inc.. Currently has a direct ownership of 3,000 shares of VIGL, which is worth approximately $4,890. The most recent transaction as insider was on Mar 28, 2022, when has been sold 3,000 shares (Common Stock) at a price of $7.2 per share, resulting in proceeds of $21,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K
0% 3M change
0% 12M change
Total Value Held $4,890

Clay Thorp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2022
BUY
Open market or private purchase
$21,600 $7.2 p/Share
3,000 Added 50.0%
3,000 Common Stock

Also insider at

PHAS
PhaseBio Pharmaceuticals Inc Healthcare
CLSD
Clearside Biomedical, Inc. Healthcare
CT

Clay Thorp

Director
Malvern, PA

Track Institutional and Insider Activities on VIGL

Follow Vigil Neuroscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIGL shares.

Notify only if

Insider Trading

Get notified when an Vigil Neuroscience, Inc. insider buys or sells VIGL shares.

Notify only if

News

Receive news related to Vigil Neuroscience, Inc.

Track Activities on VIGL